Form D · Other Health Care

PredxBio, Inc.

Pittsburgh, PA · CIK 0001751925

Offering snapshot reported Aug 17, 2023 · SEC filing

Reported sold
$601K
Offering amount: $4M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 4, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 17, 2023Initial$601,321No comparison11SEC filing
Feb 4, 2021Initial$260,000No comparison4SEC filing
Aug 14, 2020Initial$463,257No comparison7SEC filing
Aug 6, 2019Initial$275,000No comparison4SEC filing
Sep 6, 2018Initial$400,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-490035

Source: Form D, filed Aug 17, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
S. Chakra Chennubhotla Director, Executive
Srinivas Chakra Chennubhotla Director, Executive
B. Dusty Majumdar Director, Executive
Stanley Marks Director
William Newlin Director
D. Lansing Taylor Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
100 S. Jackson Ave
Pittsburgh, PA, 15202